Human Reproduction Update Advance Access published online on July 4, 2008
Human Reproduction Update, doi:10.1093/humupd/dmn026
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Low dose aspirin and IVF: Is it time for a meta-analysis continued?
Division of Endocrinology, Mubarak Al Kabeer Teaching Hospital, Jabriya, Kuwait
To whom correspondence should be addressed at: 1 Correspondence address. E-mail: sardoi@gmx.net
| The first 10% of the full text of this article appears below. |
Sir,
In their reply, Dr Gelbaya and co-authors (Gelbaya et al., 2008
) defend their meta-analysis against the criticism of Ruopp et al. (2008)
that the statistical approach and the validity of their meta-analysis on the use of low-dose aspirin in women undergoing in vitro fertilization (IVF) (Gelbaya et al., 2007
) has reached a flawed interpretation of the results. The criticism was that random-effect models have an inherent loss of precision by introducing a between-study variance. Gelbaya et